Back

Impact of functional gene groups on outcomes after ablation of ventricular tachycardia in patients with inherited left ventricular cardiomyopathy: an international multicentre study

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Ventricular tachycardia: ablation Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Yoshitaka Kimura

Leiden University Medical Center, Leiden (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Cardiac magnetic resonance to evaluate 3D ventricular substrate depth: Prognostic implications for VT ablation approach
Doctor S. Vazquez-Calvo (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
First experience of focal pulsed field ablation for premature ventricular contractions
Doctor M. Cespon Fernandez (Vigo, ES)
Abstract Slides Video
Presentation thumbnail
Substrate characterization and outcomes of ventricular tachycardia ablation in amyloid cardiomyopathy: a worldwide study
Doctor P. Compagnucci (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
Identification of reentry vulnerable targets during substrate mapping for ablation in scar related VT: the "visual" reentry vulnerability index
Doctor J. Tonko (London, GB)
Abstract Slides Video
Presentation thumbnail
Neural network for automatic ICD-EGMs matching in pace-mapping and ablation of ventricular arrhythmias.
Doctor E. Lian (Kiel, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Ventricular tachycardia: ablation
Video

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Structural heart diseases due to genetic mutations
thumbnail
Congress Presentation
Management of ventricular arrhythmias in left ventricular cardiomyopathy: aetiology matters
thumbnail
Congress Presentation
Impact of genetic variants on ablation outcomes and left ventricular function in left ventricular cardiomyopathy patients undergoing catheter ablation for atrial arrhythmias

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources